CA470573A
(en)
|
|
1951-01-02 |
Stoll Arthur |
Sympatheticolytically active dihydro-derivatives of lysergic acid amides and their manufacture
|
US2086559A
(en)
|
1936-01-30 |
1937-07-13 |
Lilly Co Eli |
Hydrogenated ergotocin
|
CH496010A
(de)
|
1967-04-20 |
1970-09-15 |
Richter Gedeon Vegyeszet |
Verfahren zur Herstellung von d-Lysergsäureamiden
|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
SE396753B
(sv)
|
1970-05-18 |
1977-10-03 |
Richter Gedeon Vegyeszet |
Analogiforfarande for framstellning av en forening tillhorande dihydrolysergsyraserien
|
US3710795A
(en)
|
1970-09-29 |
1973-01-16 |
Alza Corp |
Drug-delivery device with stretched, rate-controlling membrane
|
GB1429184A
(en)
|
1972-04-20 |
1976-03-24 |
Allen & Hanburys Ltd |
Physically anti-inflammatory steroids for use in aerosols
|
US4044126A
(en)
|
1972-04-20 |
1977-08-23 |
Allen & Hanburys Limited |
Steroidal aerosol compositions and process for the preparation thereof
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
USRE28819E
(en)
|
1972-12-08 |
1976-05-18 |
Syntex (U.S.A.) Inc. |
Dialkylated glycol compositions and medicament preparations containing same
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
US3922347A
(en)
|
1974-12-19 |
1975-11-25 |
Lilly Co Eli |
Method of inhibiting prolactin secretion with 8-acylaminoergolenes
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
CH644606A5
(de)
*
|
1980-09-23 |
1984-08-15 |
Sandoz Ag |
Verfahren zur isomerisierung von 9,10-dihydrolysergsaeurederivaten.
|
US4328245A
(en)
|
1981-02-13 |
1982-05-04 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
US4410545A
(en)
|
1981-02-13 |
1983-10-18 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
US4358603A
(en)
|
1981-04-16 |
1982-11-09 |
Syntex (U.S.A.) Inc. |
Acetal stabilized prostaglandin compositions
|
AU553809B2
(en)
|
1981-07-21 |
1986-07-31 |
Farmitalia Carlo Erba S.P.A. |
Ergoline derivatives
|
DE3135305C2
(de)
*
|
1981-09-03 |
1983-07-21 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
Verfahren zur Herstellung von 8-Ergolinyl-harnstoffen
|
US4409239A
(en)
|
1982-01-21 |
1983-10-11 |
Syntex (U.S.A.) Inc. |
Propylene glycol diester solutions of PGE-type compounds
|
CS231214B1
(en)
|
1982-03-12 |
1984-10-15 |
Antonin Cerny |
Processing method of 1-substituted n+l8alpha-ergoline+p-n,diethyl urea
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
DE3340025C2
(de)
*
|
1983-11-03 |
1986-01-09 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Verfahren zur Herstellung von 2-Brom-8-ergolinyl-Verbindungen
|
HU197569B
(en)
*
|
1984-01-12 |
1989-04-28 |
Sandoz Ag |
Process for producing 8alpha-acylaminoergoline derivatives and pharmaceuticals comprising such compounds
|
DE3413657A1
(de)
*
|
1984-04-09 |
1985-10-17 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Neue ergoline
|
DE3413660A1
(de)
*
|
1984-04-09 |
1985-10-17 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Verfahren zur herstellung von 2-(trialkyl-silyl)-ergolinderivaten
|
HU196714B
(en)
|
1984-10-04 |
1989-01-30 |
Monsanto Co |
Process for producing non-aqueous composition comprising somatotropin
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
US4679462A
(en)
|
1984-12-24 |
1987-07-14 |
Sundstrand Corporation |
Differential transmission mechanism for a constant speed drive
|
EP0208417A3
(en)
|
1985-06-12 |
1989-09-06 |
SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu |
Use of 1-(8-alpha-ergolinyl)-3,3-diethyl urea derivatives in the treatment of endometritis
|
NL8700046A
(nl)
*
|
1986-01-24 |
1987-08-17 |
Sandoz Ag |
8 alfa-acylaminoergolinen, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten.
|
DE3623503A1
(de)
*
|
1986-07-09 |
1988-01-21 |
Schering Ag |
1-aryl-ergolinyl-harnstoffderivate, verfahren zu deren herstellung sowie die verwendung dieser verbindungen als arzneimittel
|
US5033252A
(en)
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
US4828950A
(en)
|
1987-12-28 |
1989-05-09 |
Eastman Kodak Company |
Method for making multi-color reproductions on plain bond paper
|
US5668155A
(en)
|
1988-05-10 |
1997-09-16 |
The General Hospital Corporation |
Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
DE3915950A1
(de)
|
1989-05-12 |
1990-11-15 |
Schering Ag |
8(alpha)-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel
|
PH30995A
(en)
|
1989-07-07 |
1997-12-23 |
Novartis Inc |
Sustained release formulations of water soluble peptides.
|
DE3931819A1
(de)
|
1989-09-20 |
1991-03-28 |
Schering Ag |
13-brom und 13, 14-dibrom-ergoline, ihre herstellung und verwendung in arzneimitteln
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
IT1246382B
(it)
|
1990-04-17 |
1994-11-18 |
Eurand Int |
Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
US5543390A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
Covalent microparticle-drug conjugates for biological targeting
|
DE4123587A1
(de)
|
1991-07-12 |
1993-01-14 |
Schering Ag |
2,14-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US6010715A
(en)
|
1992-04-01 |
2000-01-04 |
Bertek, Inc. |
Transdermal patch incorporating a polymer film incorporated with an active agent
|
US6024975A
(en)
|
1992-04-08 |
2000-02-15 |
Americare International Diagnostics, Inc. |
Method of transdermally administering high molecular weight drugs with a polymer skin enhancer
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
TW333456B
(en)
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
US6274552B1
(en)
|
1993-03-18 |
2001-08-14 |
Cytimmune Sciences, Inc. |
Composition and method for delivery of biologically-active factors
|
US5523092A
(en)
|
1993-04-14 |
1996-06-04 |
Emory University |
Device for local drug delivery and methods for using the same
|
US5985307A
(en)
|
1993-04-14 |
1999-11-16 |
Emory University |
Device and method for non-occlusive localized drug delivery
|
US6087324A
(en)
|
1993-06-24 |
2000-07-11 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
US6004534A
(en)
|
1993-07-23 |
1999-12-21 |
Massachusetts Institute Of Technology |
Targeted polymerized liposomes for improved drug delivery
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
US5759542A
(en)
|
1994-08-05 |
1998-06-02 |
New England Deaconess Hospital Corporation |
Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases
|
US5660854A
(en)
|
1994-11-28 |
1997-08-26 |
Haynes; Duncan H |
Drug releasing surgical implant or dressing material
|
US5983134A
(en)
|
1995-04-23 |
1999-11-09 |
Electromagnetic Bracing Systems Inc. |
Electrophoretic cuff apparatus drug delivery system
|
US6316652B1
(en)
|
1995-06-06 |
2001-11-13 |
Kosta Steliou |
Drug mitochondrial targeting agents
|
EP0835101B1
(en)
|
1995-06-27 |
2004-06-09 |
Takeda Chemical Industries, Ltd. |
Method of producing sustained-release preparation
|
KR19990028818A
(ko)
|
1995-07-14 |
1999-04-15 |
와인스타인 폴 |
금속 볼 그리드 전자 패키지
|
US6167301A
(en)
|
1995-08-29 |
2000-12-26 |
Flower; Ronald J. |
Iontophoretic drug delivery device having high-efficiency DC-to-DC energy conversion circuit
|
TW448055B
(en)
|
1995-09-04 |
2001-08-01 |
Takeda Chemical Industries Ltd |
Method of production of sustained-release preparation
|
JP2909418B2
(ja)
|
1995-09-18 |
1999-06-23 |
株式会社資生堂 |
薬物の遅延放出型マイクロスフイア
|
US6039975A
(en)
|
1995-10-17 |
2000-03-21 |
Hoffman-La Roche Inc. |
Colon targeted delivery system
|
US5980945A
(en)
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
US20010016582A1
(en)
|
1997-04-28 |
2001-08-23 |
Anthony H. Cincotta |
Method and composition for the treatment of lipid and glucose metabolism disorders
|
US5877183A
(en)
|
1996-06-06 |
1999-03-02 |
Ergo Research Corporation |
Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists
|
WO1997046239A1
(en)
|
1996-06-06 |
1997-12-11 |
Ergo Research Corporation |
Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists
|
US6264970B1
(en)
|
1996-06-26 |
2001-07-24 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
US6419961B1
(en)
|
1996-08-29 |
2002-07-16 |
Takeda Chemical Industries, Ltd. |
Sustained release microcapsules of a bioactive substance and a biodegradable polymer
|
US5985317A
(en)
|
1996-09-06 |
1999-11-16 |
Theratech, Inc. |
Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
|
CA2266629C
(en)
|
1996-10-01 |
2002-04-16 |
Cima Labs Inc. |
Taste-masked microcapsule compositions and methods of manufacture
|
CA2217134A1
(en)
|
1996-10-09 |
1998-04-09 |
Sumitomo Pharmaceuticals Co., Ltd. |
Sustained release formulation
|
US6221070B1
(en)
|
1996-10-18 |
2001-04-24 |
Irvine Biomedical, Inc. |
Steerable ablation catheter system having disposable shaft
|
ATE272394T1
(de)
|
1996-10-31 |
2004-08-15 |
Takeda Chemical Industries Ltd |
Zubereitung mit verzögerter freisetzung
|
US6131570A
(en)
|
1998-06-30 |
2000-10-17 |
Aradigm Corporation |
Temperature controlling device for aerosol drug delivery
|
KR20000057693A
(ko)
|
1996-12-20 |
2000-09-25 |
다케다 야쿠힌 고교 가부시키가이샤 |
지효성 제제의 제조 방법
|
US5891474A
(en)
|
1997-01-29 |
1999-04-06 |
Poli Industria Chimica, S.P.A. |
Time-specific controlled release dosage formulations and method of preparing same
|
US5860957A
(en)
|
1997-02-07 |
1999-01-19 |
Sarcos, Inc. |
Multipathway electronically-controlled drug delivery system
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
US6060082A
(en)
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
GB9711043D0
(en)
|
1997-05-29 |
1997-07-23 |
Ciba Geigy Ag |
Organic compounds
|
US5948433A
(en)
|
1997-08-21 |
1999-09-07 |
Bertek, Inc. |
Transdermal patch
|
US6127363A
(en)
|
1997-10-28 |
2000-10-03 |
Vivus, Inc. |
Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
AU730850B2
(en)
|
1997-10-28 |
2001-03-15 |
Bando Chemical Industries, Ltd. |
A transdermal patch and a method for manufacture of a substrate sheet therefor
|
US6548490B1
(en)
|
1997-10-28 |
2003-04-15 |
Vivus, Inc. |
Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
US6156753A
(en)
|
1997-10-28 |
2000-12-05 |
Vivus, Inc. |
Local administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
US6403597B1
(en)
|
1997-10-28 |
2002-06-11 |
Vivus, Inc. |
Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
|
US6037346A
(en)
|
1997-10-28 |
2000-03-14 |
Vivus, Inc. |
Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
TR200002059T2
(tr)
|
1998-01-16 |
2001-01-22 |
Takeda Chemical Industries, Ltd. |
Devamlı salınan bileşim, üretim yöntemi ve kullanımı.
|
US6613358B2
(en)
|
1998-03-18 |
2003-09-02 |
Theodore W. Randolph |
Sustained-release composition including amorphous polymer
|
US6048736A
(en)
|
1998-04-29 |
2000-04-11 |
Kosak; Kenneth M. |
Cyclodextrin polymers for carrying and releasing drugs
|
FR2778662B1
(fr)
|
1998-05-12 |
2000-06-16 |
Adir |
Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
KR19990085365A
(ko)
|
1998-05-16 |
1999-12-06 |
허영섭 |
지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법
|
US7238711B1
(en)
|
1999-03-17 |
2007-07-03 |
Cambridge University Technical Services Ltd. |
Compounds and methods to inhibit or augment an inflammatory response
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6271359B1
(en)
|
1999-04-14 |
2001-08-07 |
Musc Foundation For Research Development |
Tissue-specific and pathogen-specific toxic agents and ribozymes
|
US6256533B1
(en)
|
1999-06-09 |
2001-07-03 |
The Procter & Gamble Company |
Apparatus and method for using an intracutaneous microneedle array
|
US6323241B1
(en)
|
2000-01-10 |
2001-11-27 |
Nexmed (Holdings) Inc. |
Prostaglandin compositions and methods of treatment for male erectile dysfunction
|
US7105571B2
(en)
|
2000-01-10 |
2006-09-12 |
Nexmed Holdings, Inc. |
Prostaglandin compositions and methods of treatment for male erectile dysfunction
|
US6693135B2
(en)
|
2000-01-10 |
2004-02-17 |
Nexmed (Holdings) Incorporated |
Prostaglandin compositions and methods of treatment for male erectile dysfunction
|
US6261595B1
(en)
|
2000-02-29 |
2001-07-17 |
Zars, Inc. |
Transdermal drug patch with attached pocket for controlled heating device
|
US6495154B1
(en)
|
2000-11-21 |
2002-12-17 |
Vivus Inc. |
On demand administration of clomipramine and salts thereof to treat premature ejaculation
|
EP1392262A1
(en)
|
2001-05-24 |
2004-03-03 |
Alexza Molecular Delivery Corporation |
Delivery of drug esters through an inhalation route
|
ATE424414T1
(de)
|
2001-06-08 |
2009-03-15 |
Sod Conseils Rech Applic |
Chimere somatostatin-dopamin-analoga
|
JP4271028B2
(ja)
*
|
2001-08-10 |
2009-06-03 |
久光製薬株式会社 |
経皮吸収型製剤
|
DE10249401A1
(de)
|
2002-10-23 |
2004-05-13 |
Bernina Biosystems Gmbh |
Liposomen formende Zusammensetzung
|
JP4579235B2
(ja)
|
2003-04-11 |
2010-11-10 |
イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ |
ソマトスタチン−ドーパミンキメラ類似体
|
CA2538237A1
(en)
|
2003-09-10 |
2005-03-24 |
Map Pharmaceuticals, Inc. |
Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
|
US7650848B2
(en)
|
2004-02-17 |
2010-01-26 |
University Of Florida Research Foundation, Inc. |
Surface topographies for non-toxic bioadhesion control
|
US9016221B2
(en)
|
2004-02-17 |
2015-04-28 |
University Of Florida Research Foundation, Inc. |
Surface topographies for non-toxic bioadhesion control
|
GB0511060D0
(en)
|
2005-05-31 |
2005-07-06 |
Novartis Ag |
Organic compounds
|
US8859579B2
(en)
|
2008-03-21 |
2014-10-14 |
Richard Andrew Sewell |
Compostions and methods for preventing and/or treating disorders associated with cephalic pain
|
US20100168119A1
(en)
|
2008-11-05 |
2010-07-01 |
Pharmorx, Inc. |
Compositions and methods for minimizing or reducing agonist-induced desensitization
|
WO2010065930A1
(en)
|
2008-12-04 |
2010-06-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for treating or preventing narcotic withdrawal symptoms
|
WO2011079313A1
(en)
|
2009-12-23 |
2011-06-30 |
Map Pharmaceuticals, Inc. |
Novel ergoline analogs
|
NZ604004A
(en)
|
2010-05-07 |
2014-06-27 |
Gilead Connecticut Inc |
Pyridone and aza-pyridone compounds and methods of use
|
AU2011328299A1
(en)
*
|
2010-11-11 |
2013-07-04 |
Sinoxa Pharma Gmbh |
Lisuride, terguride and derivatives thereof for use in the prophylaxis and/or treatment of fibrotic changes
|
WO2012177962A1
(en)
|
2011-06-23 |
2012-12-27 |
Map Pharmaceuticals, Inc. |
Novel fluoroergoline analogs
|
EP2793580A4
(en)
*
|
2011-12-19 |
2015-05-20 |
Map Pharmaceuticals Inc |
NEW DERIVATIVES OF ISO-ERGOLINE
|
US8946420B2
(en)
|
2011-12-21 |
2015-02-03 |
Map Pharmaceuticals, Inc. |
Neuromodulatory compounds
|
US9012640B2
(en)
|
2012-06-22 |
2015-04-21 |
Map Pharmaceuticals, Inc. |
Cabergoline derivatives
|
WO2014078857A1
(en)
|
2012-11-19 |
2014-05-22 |
Regents Of The University Of Minnesota |
Ergoline derivatives as dopamine receptor modulators
|
US20140179707A1
(en)
|
2012-12-21 |
2014-06-26 |
Map Pharmaceuticals, Inc. |
Novel ergoline derivatives and uses thereof
|
US8895743B2
(en)
|
2012-12-21 |
2014-11-25 |
Map Pharmaceuticals, Inc. |
Methysergide derivatives
|
HK1216250A1
(zh)
|
2012-12-21 |
2016-10-28 |
Map Pharmaceuticals, Inc. |
8'-羟基-二氢麦角胺化合物及组合物
|
WO2014100353A1
(en)
|
2012-12-21 |
2014-06-26 |
Map Pharmaceuticals, Inc. |
8'-hydroxy-dihydroergotamine compounds and compositions
|
US20140179706A1
(en)
|
2012-12-21 |
2014-06-26 |
Map Pharmaceuticals, Inc. |
Fluoroergoline derivatives and uses thereof
|
WO2014186623A2
(en)
|
2013-05-17 |
2014-11-20 |
Biomed Valley Discoveries |
Methods and compositions for the treatment of a chagas disease
|
BR112017015487A2
(pt)
|
2015-01-20 |
2018-01-30 |
Xoc Pharmaceuticals Inc |
Composto; composição; método de tratamento e/ou prevenção de enxaqueca, als, doença de alzheimer, doença de parkinson, distúrbios extrapirimidais, depressão, náusea, êmese, síndrome das pernas inquietas, insônia, agressão, doença de huntington, doença cardiopulmonar, fibrogênese, hipertensão arterial pulmonar, ansiedade, dependências a drogas, distonia, parassonia ou hiperlactinemia em um indivíduo; métodos de agonização dos receptores d2, 5-ht1d, 5-ht1a e 5-ht2c, em um indivíduo; método de antagonização do receptor d3 em um indivíduo; métodos de agonização seletiva dos receptores 5 -ht1d, e 5-ht2c, método de fornecimento de atividade de antagonista funcional no receptor 5 -ht2b ou no receptor 5-ht7, ou em ambos, em um indivíduo; método de fornecimento de atividade de antagonista funcional nos receptores adrenérgicos em um indivíduo
|
JP2018502889A
(ja)
|
2015-01-20 |
2018-02-01 |
エックスオーシー ファーマシューティカルズ インコーポレイテッドXoc Pharmaceuticals, Inc |
イソエルゴリン化合物およびその使用
|